SG156658A1 - Treatment of diseases - Google Patents

Treatment of diseases

Info

Publication number: SG156658A1
Authority: SG; Singapore
Prior art keywords: treatment; diseases; methods; demyelinating; disorders
Prior art date: 2004-04-05

Application number

SG200906975-8A

Other languages

English (en)

Inventor

Bryan Youl

Original Assignee

Aimsco Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-05

Filing date

2005-04-01

Publication date

2009-11-26

2004-04-05 Priority claimed from GB0407710A external-priority patent/GB0407710D0/en

2004-05-17 Priority claimed from GB0410966A external-priority patent/GB0410966D0/en

2005-04-01 Application filed by Aimsco Ltd filed Critical Aimsco Ltd

2009-11-26 Publication of SG156658A1 publication Critical patent/SG156658A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Cell Biology (AREA)
Hematology (AREA)
Microbiology (AREA)
Mycology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)

SG200906975-8A 2004-04-05 2005-04-01 Treatment of diseases SG156658A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0407710A GB0407710D0 (en)	2004-04-05	2004-04-05	Treatment of diseases
GB0410966A GB0410966D0 (en)	2004-05-17	2004-05-17	Treatment of neural disorders

Publications (1)

Publication Number	Publication Date
SG156658A1 true SG156658A1 (en)	2009-11-26

Family

ID=35125620

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SG2013028972A SG189794A1 (en)	2004-04-05	2005-04-01	Treatment of diseases
SG200906975-8A SG156658A1 (en)	2004-04-05	2005-04-01	Treatment of diseases
SG2013028998A SG189796A1 (en)	2004-04-05	2005-04-01	Treatment of diseases

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SG2013028972A SG189794A1 (en)	2004-04-05	2005-04-01	Treatment of diseases

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG2013028998A SG189796A1 (en)	2004-04-05	2005-04-01	Treatment of diseases

Country Status (19)

Country	Link
US (4)	US20080233112A1 (fr)
EP (3)	EP1732648B1 (fr)
JP (1)	JP2007531789A (fr)
KR (1)	KR101226605B1 (fr)
AT (1)	ATE451145T1 (fr)
AU (1)	AU2005230706B2 (fr)
BR (1)	BRPI0509629A (fr)
CA (1)	CA2562223C (fr)
DE (1)	DE602005018179D1 (fr)
DK (3)	DK2591822T3 (fr)
EA (1)	EA014225B1 (fr)
ES (2)	ES2339035T3 (fr)
IL (1)	IL178490A (fr)
MX (1)	MXPA06011554A (fr)
NZ (1)	NZ550405A (fr)
PL (2)	PL2591822T3 (fr)
PT (1)	PT2591822E (fr)
SG (3)	SG189794A1 (fr)
WO (1)	WO2005097183A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0415359D0 (en) *	2004-07-08	2004-08-11	Aimsco Ltd	Medicament
GB0509052D0 (en) *	2005-05-04	2005-06-08	Aimsco Ltd	Combination therapy
GB0910032D0 (en) *	2009-06-11	2009-07-22	Aimsco Ltd	Use of serum composition to reduce the levels of TNF and/or VEGF in mammals
WO2014001749A1 (fr)	2012-06-25	2014-01-03	Aimsco Limited	Formulation comprenant crh et l'alpha-2-immunoglobuline

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7147854B2 (en) *	1997-06-23	2006-12-12	Yes Biotech Laboratories Ltd.	Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
WO2003064472A2 (fr)	2002-01-28	2003-08-07	Aimsco Limited	Traitement
AU2002317285B2 (en) *	2001-07-02	2007-05-24	Aimsco Limited	Use of polyclonal anti-HIV goat serum as a therapeutic agent
JPWO2003063905A1 (ja) *	2002-01-31	2005-05-26	株式会社東京大学Ｔｌｏ	免疫疾患の予防又は治療剤

2005
- 2005-04-01 ES ES05718137T patent/ES2339035T3/es not_active Expired - Lifetime
- 2005-04-01 BR BRPI0509629-4A patent/BRPI0509629A/pt not_active IP Right Cessation
- 2005-04-01 WO PCT/GB2005/050046 patent/WO2005097183A2/fr not_active Ceased
- 2005-04-01 DK DK12195358.2T patent/DK2591822T3/en active
- 2005-04-01 ES ES12195358.2T patent/ES2561291T3/es not_active Expired - Lifetime
- 2005-04-01 PT PT121953582T patent/PT2591822E/pt unknown
- 2005-04-01 SG SG2013028972A patent/SG189794A1/en unknown
- 2005-04-01 AT AT05718137T patent/ATE451145T1/de active
- 2005-04-01 KR KR1020067023249A patent/KR101226605B1/ko not_active Expired - Fee Related
- 2005-04-01 EA EA200601876A patent/EA014225B1/ru not_active IP Right Cessation
- 2005-04-01 US US11/547,644 patent/US20080233112A1/en not_active Abandoned
- 2005-04-01 EP EP05718137A patent/EP1732648B1/fr not_active Expired - Lifetime
- 2005-04-01 PL PL12195358T patent/PL2591822T3/pl unknown
- 2005-04-01 DK DK05718137.2T patent/DK1732648T3/da active
- 2005-04-01 EP EP12195358.2A patent/EP2591822B1/fr not_active Expired - Lifetime
- 2005-04-01 SG SG200906975-8A patent/SG156658A1/en unknown
- 2005-04-01 AU AU2005230706A patent/AU2005230706B2/en not_active Ceased
- 2005-04-01 DK DK09178431.4T patent/DK2184085T3/en active
- 2005-04-01 JP JP2007506843A patent/JP2007531789A/ja active Pending
- 2005-04-01 CA CA2562223A patent/CA2562223C/fr not_active Expired - Lifetime
- 2005-04-01 MX MXPA06011554A patent/MXPA06011554A/es active IP Right Grant
- 2005-04-01 DE DE602005018179T patent/DE602005018179D1/de not_active Expired - Lifetime
- 2005-04-01 PL PL05718137T patent/PL1732648T3/pl unknown
- 2005-04-01 SG SG2013028998A patent/SG189796A1/en unknown
- 2005-04-01 NZ NZ550405A patent/NZ550405A/en not_active IP Right Cessation
- 2005-04-01 EP EP09178431.4A patent/EP2184085B1/fr not_active Expired - Lifetime
2006
- 2006-10-05 IL IL178490A patent/IL178490A/en not_active IP Right Cessation
2012
- 2012-07-09 US US13/544,026 patent/US20130156751A1/en not_active Abandoned
2013
- 2013-12-26 US US14/141,347 patent/US20140105998A1/en not_active Abandoned
2015
- 2015-12-14 US US14/968,889 patent/US20160101131A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2005097183A3 (fr)	2006-04-20
EA014225B1 (ru)	2010-10-29
DK1732648T3 (da)	2010-04-26
CA2562223C (fr)	2017-03-21
AU2005230706B2 (en)	2011-08-11
US20140105998A1 (en)	2014-04-17
DE602005018179D1 (de)	2010-01-21
EP2184085A1 (fr)	2010-05-12
BRPI0509629A (pt)	2007-09-18
SG189796A1 (en)	2013-05-31
EP1732648A2 (fr)	2006-12-20
JP2007531789A (ja)	2007-11-08
ES2339035T3 (es)	2010-05-14
EP2184085B1 (fr)	2014-11-05
EA200601876A1 (ru)	2007-02-27
DK2184085T3 (en)	2014-11-17
IL178490A0 (en)	2007-02-11
EP1732648B1 (fr)	2009-12-09
EP2591822B1 (fr)	2015-11-18
WO2005097183A2 (fr)	2005-10-20
US20160101131A1 (en)	2016-04-14
SG189794A1 (en)	2013-05-31
DK2591822T3 (en)	2016-02-22
NZ550405A (en)	2009-04-30
ES2561291T3 (es)	2016-02-25
PL1732648T3 (pl)	2010-07-30
ATE451145T1 (de)	2009-12-15
MXPA06011554A (es)	2007-05-07
US20130156751A1 (en)	2013-06-20
US20080233112A1 (en)	2008-09-25
CA2562223A1 (fr)	2005-10-20
PL2591822T3 (pl)	2016-05-31
IL178490A (en)	2010-11-30
KR20070036041A (ko)	2007-04-02
EP2591822A1 (fr)	2013-05-15
KR101226605B1 (ko)	2013-01-28
AU2005230706A1 (en)	2005-10-20
PT2591822E (pt)	2016-03-11

Publication	Publication Date	Title
TW200738270A (en)	2007-10-16	Method of treating depression using a TNFα antibody
SI1734995T1 (sl)	2010-09-30	Monoklonska protitelesa proti hepatocitnemu rastnemu faktorju
MXPA03011515A (es)	2004-03-18	Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
PL397846A1 (pl)	2012-05-21	Leczenie zaburzeń związanych z TNFα
IL175158A0 (en)	2006-09-05	Tocopherol-modified therapeutic drug compounds
TW200528117A (en)	2005-09-01	Methods and reagents for the treatment of proliferative diseases
TW200600087A (en)	2006-01-01	Methods and compositions for treating amyloid-related diseases
UA96115C2 (uk)	2011-10-10	Спосіб і композиція для лікування амілоїдогенних захворювань
WO2003096977A3 (fr)	2004-03-11	Methodes de traitement de l'hepatite
EA200601837A1 (ru)	2007-04-27	Бензоксазины для лечения заболеваний дыхательных путей
WO2006009765A3 (fr)	2006-05-11	Procedes d'identification et d'utilisation de composes adaptes au traitement de cellules cancereuses resistantes aux medicaments
TW200507840A (en)	2005-03-01	Method of treating multiple myeloma
EA200501821A1 (ru)	2006-06-30	Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
EP2107071A3 (fr)	2009-12-30	Iimmunoglobulines anti-epcam
WO2004073615A3 (fr)	2005-06-16	Composes de deazaflavine et leurs methodes d'utilisation
CY1109666T1 (el)	2014-08-13	Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
WO2006023452A3 (fr)	2006-12-28	Analogues de la cyclosporine utilises pour le traitement de troubles immunoregulateurs et de maladies respiratoires
SG156658A1 (en)	2009-11-26	Treatment of diseases
DK1596879T3 (da)	2011-04-11	Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
WO2002069944A3 (fr)	2003-10-02	Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1
BR0308753A (pt)	2005-01-11	Método para produzir pseudo-ilhotas
WO2006056463A3 (fr)	2006-07-27	Procedes pour produire des conjugues d'albumine au moyen d'anti-inflammatoires non steroides contre les rhumatismes (nsar)
UA2986U (uk)	2004-09-15	Спосіб лікування розсіяного склерозу
UA3978U (uk)	2004-12-15	Спосіб лікування компресійних нейропатій черепно-мозкових нервів у хворих після реконструктивних операцій на прецеребральних артеріях
WO2005058235A3 (fr)	2005-09-22	Methodes utilisant le sulodexide dans le traitement des maladies de la vessie